HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HIGHTIDE-B

3.440

+0.0501.47%

Volume:670.50K

Turnover:2.30M

Market Cap:1.96B

PE:-4.07

High:3.500

Open:3.300

Low:3.290

Close:3.390

52wk High:4.700

52wk Low:1.100

Shares:571.00M

HK Float Shares:571.00M

Volume Ratio:0.61

T/O Rate:0.12%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.845

ROE:-62.13%

ROA:-35.29%

PB:5.46

PE(LYR):-4.07

PS:50.34

Loading ...

Overview Company News Filings

HighTide Therapeutics-B (2511) Schedules 27 March 2026 Board Meeting to Approve FY 2025 Audited Results

Bulletin Express

HighTide Therapeutics Gets China Acceptance for Type 2 Diabetes Mellitus Drug

MT Newswires Live

BRIEF-HighTide Therapeutics Says NMPA China Accepts New Drug Application For HTD1801

HighTide-B (02511.HK) Secures NMPA Acceptance of First NDA for HTD1801 in Type 2 Diabetes

Bulletin Express

HIGHTIDE-B Receives NMPA Acceptance for New Drug Application of HTD1801

China NMPA accepts HighTide Therapeutics’ HTD1801 NDA for type 2 diabetes

HighTide Therapeutics Inc - Acceptance of New Drug Application for Htd1801 by China's Nmpa

THOMSON REUTERS

HighTide Therapeutics (02511) Announces February 2026 Monthly Return with No Changes in Share Capital

Bulletin Express

HIGHTIDE-B Completes Phase IIb Trial of HTD1801 for Metabolic Dysfunction-Associated Steatohepatitis

HighTide Therapeutics (2511) Completes Phase IIb Trial for HTD1801 in MASH Treatment

Bulletin Express

Hightide Therapeutics Completes Phase IIb Trial of HTD1801 for MASH Treatment

HighTide Therapeutics (02511) Announces January 2026 Monthly Return

Bulletin Express

HighTide Therapeutics (2511) Announces Appointment of Chief Medical Officer to Advance CKM Portfolio

Bulletin Express

HighTide Therapeutics Appoints Chief Medical Officer

MT Newswires Live

HIGHTIDE-B (02511) Appoints Dr. Filip Surmont as Chief Medical Officer to Strengthen CKM Disease Portfolio

HighTide Therapeutics Appoints Dr. Filip Surmont as Chief Medical Officer

Huatai Securities International Initiates Coverage on HIGHTIDE-B (02511) with "Buy" Rating, Sets Target Price at HK$5.78

10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled

HighTide Therapeutics (02511) Releases Monthly Return for November 2025

Bulletin Express

HighTide Therapeutics (2511.HK) Reports Positive Phase III HARMONY Trial Results for HTD1801 in T2DM

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/02511/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02511","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02511\",,,,,undefined,":{"symbol":"02511","market":"HK","secType":"STK","nameCN":"HIGHTIDE-B","latestPrice":3.44,"timestamp":1773821283916,"preClose":3.39,"halted":0,"volume":670500,"delay":0,"changeRate":0.014749262536873104,"floatShares":571000000,"shares":571000000,"eps":-0.84452,"marketStatus":"Closed","change":0.05,"latestTime":"03-18 16:08:03","open":3.3,"high":3.5,"low":3.29,"amount":2296105,"amplitude":0.061947,"askPrice":3.44,"askSize":10500,"bidPrice":3.4,"bidSize":23500,"shortable":0,"etf":0,"ttmEps":-0.559,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1773883800000},"marketStatusCode":5,"adr":0,"listingDate":1703174400000,"exchange":"SEHK","adjPreClose":3.39,"openAndCloseTimeList":[[1773797400000,1773806400000],[1773810000000,1773820800000]],"volumeRatio":0.611658,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02511\",,,,,undefined,":{"symbol":"02511","floatShares":571000000,"roa":"-35.29%","roe":"-62.13%","lyrEps":-0.84452,"volumeRatio":0.611658,"shares":571000000,"dividePrice":0,"high":3.5,"amplitude":0.061947,"preClose":3.39,"low":3.29,"week52Low":1.1,"pbRate":"5.46","psRate":"50.34","week52High":4.7,"institutionHeld":0,"latestPrice":3.44,"committee":0.382353,"eps":-0.84452,"divideRate":0,"volume":670500,"delay":0,"ttmEps":-0.559,"open":3.3,"prevYearClose":2.95,"prevWeekClose":3.03,"prevMonthClose":2.31,"prevQuarterClose":2.95,"fiveDayClose":3,"twentyDayClose":2.6,"sixtyDayClose":2.61,"earningDate":1774540800000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02511\",params:#limit:5,,,undefined,":[{"date":"2026-03-27","symbol":"02511","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774575000000,"name":null,"time":"","dateTimestamp":1774540800000,"actualEps":null},{"date":"2025-03-28","symbol":"02511","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743125400000,"name":null,"time":"Post Market","dateTimestamp":1743091200000,"actualEps":null},{"market":"HK","date":"2024-08-28","symbol":"02511","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1724774400000,"reportTimeType":"post","actualEps":null},{"date":"2024-03-27","symbol":"02511","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711503000000,"name":null,"time":"","dateTimestamp":1711468800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02511\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02511\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02511\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02511","date":"2026-03-17","current":-6.08229,"percent":0.186131,"low":-9.095359,"twenty":-5.465819,"median":-3.276878,"eighty":-0.891635,"high":-0.503695,"avg":-3.490697,"sd":2.502824,"marketCap":1936794014},"quantilePoints":[{"date":"2023-12-22","current":-8.734639,"twenty":-8.492642,"median":-8.129647,"eighty":-8.127643,"marketCap":6372860869},{"date":"2023-12-29","current":-9.095359,"twenty":-8.98365,"median":-8.695581,"eighty":-8.129647,"marketCap":6671427857},{"date":"2024-01-05","current":-8.537988,"twenty":-8.784441,"median":-8.544038,"eighty":-8.248369,"marketCap":6218429669},{"date":"2024-01-12","current":-8.363907,"twenty":-8.685299,"median":-8.537988,"eighty":-8.346736,"marketCap":6094884709},{"date":"2024-01-19","current":-8.1349,"twenty":-8.659812,"median":-8.456167,"eighty":-8.207816,"marketCap":5919862682},{"date":"2024-01-26","current":-8.649584,"twenty":-8.650972,"median":-8.460912,"eighty":-8.207816,"marketCap":6269906736},{"date":"2024-02-02","current":-8.361984,"twenty":-8.650972,"median":-8.483943,"eighty":-8.264989,"marketCap":6053703055},{"date":"2024-02-09","current":-8.504973,"twenty":-8.597346,"median":-8.473421,"eighty":-8.275661,"marketCap":6187543429},{"date":"2024-02-16","current":-8.602173,"twenty":-8.63062,"median":-8.476958,"eighty":-8.294295,"marketCap":6259611322},{"date":"2024-02-23","current":-8.036159,"twenty":-8.595019,"median":-8.473421,"eighty":-8.208635,"marketCap":5816908548},{"date":"2024-03-01","current":-7.945863,"twenty":-8.576687,"median":-8.451284,"eighty":-8.127643,"marketCap":5755136068},{"date":"2024-03-08","current":-6.052653,"twenty":-8.560192,"median":-8.40877,"eighty":-7.978802,"marketCap":4385846091},{"date":"2024-03-15","current":-5.695388,"twenty":-8.551566,"median":-8.362945,"eighty":-7.867218,"marketCap":4123313050},{"date":"2024-03-22","current":-4.312815,"twenty":-8.548208,"median":-8.27805,"eighty":-6.066123,"marketCap":3119510248},{"date":"2024-03-28","current":-2.992001,"twenty":-8.543906,"median":-8.212744,"eighty":-5.745595,"marketCap":3042294647},{"date":"2024-04-05","current":-2.73463,"twenty":-8.539468,"median":-8.197001,"eighty":-5.576119,"marketCap":2779761607},{"date":"2024-04-12","current":-2.176341,"twenty":-8.534781,"median":-8.129647,"eighty":-4.493311,"marketCap":2213513872},{"date":"2024-04-19","current":-2.517594,"twenty":-8.523109,"median":-8.043912,"eighty":-4.309916,"marketCap":2558410219},{"date":"2024-04-26","current":-2.586635,"twenty":-8.508057,"median":-7.951497,"eighty":-2.864821,"marketCap":2625330406},{"date":"2024-05-03","current":-2.649329,"twenty":-8.498668,"median":-7.924262,"eighty":-2.751198,"marketCap":2687102886},{"date":"2024-05-10","current":-3.422806,"twenty":-8.484817,"median":-7.769212,"eighty":-2.737043,"marketCap":3479849715},{"date":"2024-05-17","current":-3.275714,"twenty":-8.477244,"median":-6.276091,"eighty":-2.747016,"marketCap":3325418515},{"date":"2024-05-24","current":-2.698739,"twenty":-8.474688,"median":-5.875073,"eighty":-2.745416,"marketCap":2733432247},{"date":"2024-05-31","current":-2.594452,"twenty":-8.468417,"median":-5.713034,"eighty":-2.710462,"marketCap":2630478113},{"date":"2024-06-07","current":-2.277412,"twenty":-8.457116,"median":-5.462224,"eighty":-2.655805,"marketCap":2306172592},{"date":"2024-06-14","current":-2.08615,"twenty":-8.451368,"median":-5.115854,"eighty":-2.588198,"marketCap":2110559738},{"date":"2024-06-21","current":-1.830485,"twenty":-8.444904,"median":-4.331734,"eighty":-2.536299,"marketCap":1848026698},{"date":"2024-06-28","current":-0.719236,"twenty":-8.417702,"median":-4.312815,"eighty":-2.477957,"marketCap":725826641},{"date":"2024-07-05","current":-0.596943,"twenty":-8.40877,"median":-4.051691,"eighty":-2.463651,"marketCap":602281681},{"date":"2024-07-12","current":-0.636823,"twenty":-8.366276,"median":-3.549353,"eighty":-2.277412,"marketCap":643463335},{"date":"2024-07-19","current":-0.560394,"twenty":-8.363907,"median":-3.496298,"eighty":-2.190964,"marketCap":566247734},{"date":"2024-07-26","current":-0.517715,"twenty":-8.361984,"median":-3.220684,"eighty":-2.08615,"marketCap":525066081},{"date":"2024-08-02","current":-0.75671,"twenty":-8.318662,"median":-2.992001,"eighty":-1.873562,"marketCap":767008295},{"date":"2024-08-09","current":-0.776926,"twenty":-8.27805,"median":-2.863181,"eighty":-0.894876,"marketCap":792746828},{"date":"2024-08-16","current":-0.766537,"twenty":-8.266106,"median":-2.770601,"eighty":-0.773016,"marketCap":782451415},{"date":"2024-08-23","current":-0.652832,"twenty":-8.212744,"median":-2.747107,"eighty":-0.75671,"marketCap":669201868},{"date":"2024-08-30","current":-1.100172,"twenty":-8.205896,"median":-2.728047,"eighty":-0.729206,"marketCap":725826641},{"date":"2024-09-06","current":-0.912468,"twenty":-8.188106,"median":-2.679629,"eighty":-0.740924,"marketCap":602281681},{"date":"2024-09-13","current":-0.656825,"twenty":-8.1349,"median":-2.649329,"eighty":-0.723174,"marketCap":432407361},{"date":"2024-09-20","current":-0.691774,"twenty":-8.130698,"median":-2.594452,"eighty":-0.718911,"marketCap":458145894},{"date":"2024-09-27","current":-0.788079,"twenty":-8.126975,"median":-2.574831,"eighty":-0.711909,"marketCap":525066081},{"date":"2024-10-04","current":-0.892575,"twenty":-8.081521,"median":-2.538273,"eighty":-0.714203,"marketCap":591986268},{"date":"2024-10-10","current":-0.882415,"twenty":-8.045462,"median":-2.524212,"eighty":-0.716377,"marketCap":581690854},{"date":"2024-10-18","current":-0.879542,"twenty":-8.029599,"median":-2.476753,"eighty":-0.71826,"marketCap":576543148},{"date":"2024-10-25","current":-0.879598,"twenty":-7.992455,"median":-2.46526,"eighty":-0.719628,"marketCap":576543148},{"date":"2024-11-01","current":-0.933943,"twenty":-7.949243,"median":-2.40723,"eighty":-0.720238,"marketCap":612577094},{"date":"2024-11-08","current":-0.972706,"twenty":-7.937223,"median":-2.272633,"eighty":-0.721432,"marketCap":633167921},{"date":"2024-11-15","current":-0.836682,"twenty":-7.912537,"median":-2.191611,"eighty":-0.725587,"marketCap":540509201},{"date":"2024-11-22","current":-0.837164,"twenty":-7.876462,"median":-2.165315,"eighty":-0.733893,"marketCap":540509201},{"date":"2024-11-29","current":-0.781798,"twenty":-7.785116,"median":-2.08615,"eighty":-0.746636,"marketCap":504475254},{"date":"2024-12-06","current":-0.799637,"twenty":-7.200158,"median":-1.899521,"eighty":-0.755806,"marketCap":514770668},{"date":"2024-12-13","current":-0.768352,"twenty":-6.314044,"median":-1.830485,"eighty":-0.757354,"marketCap":494179841},{"date":"2024-12-20","current":-0.917454,"twenty":-6.072858,"median":-1.096301,"eighty":-0.757354,"marketCap":586838561},{"date":"2024-12-27","current":-1.047032,"twenty":-6.052653,"median":-1.059897,"eighty":-0.758321,"marketCap":669201868},{"date":"2025-01-03","current":-0.89313,"twenty":-5.910589,"median":-1.030203,"eighty":-0.759127,"marketCap":571395441},{"date":"2025-01-10","current":-0.872296,"twenty":-5.819219,"median":-1.016579,"eighty":-0.765095,"marketCap":555952321},{"date":"2025-01-17","current":-0.928085,"twenty":-5.745595,"median":-0.982343,"eighty":-0.767989,"marketCap":591986268},{"date":"2025-01-24","current":-0.890226,"twenty":-5.702446,"median":-0.971737,"eighty":-0.768352,"marketCap":571395441},{"date":"2025-01-28","current":-0.909941,"twenty":-5.677229,"median":-0.965955,"eighty":-0.76868,"marketCap":586838561},{"date":"2025-02-07","current":-0.962836,"twenty":-5.576119,"median":-0.960006,"eighty":-0.770428,"marketCap":617724801},{"date":"2025-02-14","current":-0.916884,"twenty":-5.437951,"median":-0.957687,"eighty":-0.772342,"marketCap":586838561},{"date":"2025-02-21","current":-1.079861,"twenty":-5.295856,"median":-0.96114,"eighty":-0.773201,"marketCap":694940401},{"date":"2025-02-28","current":-0.922924,"twenty":-4.99937,"median":-0.960573,"eighty":-0.77414,"marketCap":591986268},{"date":"2025-03-07","current":-0.807326,"twenty":-4.493311,"median":-0.957265,"eighty":-0.775085,"marketCap":519918374},{"date":"2025-03-14","current":-0.966841,"twenty":-4.332382,"median":-0.951297,"eighty":-0.775904,"marketCap":622872508},{"date":"2025-03-21","current":-1.151073,"twenty":-4.329727,"median":-0.958109,"eighty":-0.776927,"marketCap":741269761},{"date":"2025-03-28","current":-1.305593,"twenty":-4.323383,"median":-0.961988,"eighty":-0.77695,"marketCap":839076188},{"date":"2025-04-03","current":-1.964669,"twenty":-4.312815,"median":-0.968609,"eighty":-0.77703,"marketCap":803042242},{"date":"2025-04-11","current":-1.804502,"twenty":-4.298321,"median":-0.972706,"eighty":-0.779537,"marketCap":730974348},{"date":"2025-04-17","current":-2.094006,"twenty":-4.101017,"median":-0.982343,"eighty":-0.781346,"marketCap":849371602},{"date":"2025-04-25","current":-2.153289,"twenty":-3.838494,"median":-0.984395,"eighty":-0.781962,"marketCap":875110135},{"date":"2025-05-02","current":-2.275118,"twenty":-3.638788,"median":-0.998444,"eighty":-0.782191,"marketCap":926587202},{"date":"2025-05-09","current":-3.363784,"twenty":-3.551198,"median":-1.021661,"eighty":-0.782445,"marketCap":1379585390},{"date":"2025-05-16","current":-3.99636,"twenty":-3.977419,"median":-1.026921,"eighty":-0.783805,"marketCap":1652413844},{"date":"2025-05-23","current":-3.475525,"twenty":-3.891419,"median":-1.043315,"eighty":-0.788891,"marketCap":1441357870},{"date":"2025-05-30","current":-2.595234,"twenty":-3.819658,"median":-1.05978,"eighty":-0.79364,"marketCap":1081018402},{"date":"2025-06-06","current":-3.217297,"twenty":-3.690833,"median":-1.079861,"eighty":-0.799918,"marketCap":1343551443},{"date":"2025-06-13","current":-3.979986,"twenty":-3.819658,"median":-1.125622,"eighty":-0.801093,"marketCap":1662709257},{"date":"2025-06-20","current":-3.555688,"twenty":-3.891829,"median":-1.260849,"eighty":-0.802505,"marketCap":1482539523},{"date":"2025-06-27","current":-3.398018,"twenty":-3.858555,"median":-1.338636,"eighty":-0.807993,"marketCap":1420767043},{"date":"2025-07-04","current":-3.348614,"twenty":-3.850482,"median":-1.395853,"eighty":-0.810663,"marketCap":1400176216},{"date":"2025-07-11","current":-4.33787,"twenty":-3.901653,"median":-1.565723,"eighty":-0.818449,"marketCap":1811992751},{"date":"2025-07-18","current":-4.941417,"twenty":-4.032449,"median":-1.709388,"eighty":-0.827717,"marketCap":2062485661},{"date":"2025-07-25","current":-4.84168,"twenty":-4.072278,"median":-1.830485,"eighty":-0.829191,"marketCap":2028206121},{"date":"2025-08-01","current":-4.226787,"twenty":-4.272195,"median":-1.888937,"eighty":-0.829739,"marketCap":1759683057},{"date":"2025-08-08","current":-4.394198,"twenty":-4.326025,"median":-1.964669,"eighty":-0.830438,"marketCap":1833955394},{"date":"2025-08-15","current":-4.551598,"twenty":-4.330653,"median":-2.021536,"eighty":-0.833182,"marketCap":1896801217},{"date":"2025-08-22","current":-4.428389,"twenty":-4.337848,"median":-2.077326,"eighty":-0.833612,"marketCap":1839668650},{"date":"2025-08-29","current":-6.120211,"twenty":-4.380509,"median":-2.09259,"eighty":-0.836682,"marketCap":1948220527},{"date":"2025-09-05","current":-6.359835,"twenty":-4.480886,"median":-2.122167,"eighty":-0.837164,"marketCap":2022492864},{"date":"2025-09-12","current":-7.854809,"twenty":-4.551598,"median":-2.149237,"eighty":-0.837164,"marketCap":2502406425},{"date":"2025-09-19","current":-7.860387,"twenty":-4.786316,"median":-2.153472,"eighty":-0.838292,"marketCap":2502406425},{"date":"2025-09-26","current":-7.017182,"twenty":-4.941417,"median":-2.183652,"eighty":-0.84547,"marketCap":2228170105},{"date":"2025-10-03","current":-7.036374,"twenty":-5.00868,"median":-2.202955,"eighty":-0.847167,"marketCap":2239596618},{"date":"2025-10-10","current":-6.399502,"twenty":-5.389404,"median":-2.271485,"eighty":-0.847613,"marketCap":2033919378},{"date":"2025-10-17","current":-6.134636,"twenty":-5.76051,"median":-2.316794,"eighty":-0.84775,"marketCap":1948220527},{"date":"2025-10-24","current":-6.635946,"twenty":-5.949231,"median":-2.385869,"eighty":-0.85134,"marketCap":2108191714},{"date":"2025-10-31","current":-6.715847,"twenty":-6.05096,"median":-2.429559,"eighty":-0.85508,"marketCap":2136757998},{"date":"2025-11-07","current":-5.803675,"twenty":-6.064964,"median":-2.466868,"eighty":-0.858385,"marketCap":1845381907},{"date":"2025-11-14","current":-5.357261,"twenty":-6.05096,"median":-2.479762,"eighty":-0.861761,"marketCap":1708263747},{"date":"2025-11-21","current":-5.162577,"twenty":-6.038234,"median":-2.53083,"eighty":-0.864616,"marketCap":1645417923},{"date":"2025-11-28","current":-5.001007,"twenty":-6.009542,"median":-2.552457,"eighty":-0.867916,"marketCap":1599711870},{"date":"2025-12-05","current":-5.349025,"twenty":-5.978814,"median":-2.586635,"eighty":-0.871961,"marketCap":1713977004},{"date":"2025-12-12","current":-4.983206,"twenty":-5.953787,"median":-2.601318,"eighty":-0.872449,"marketCap":1599711870},{"date":"2025-12-19","current":-4.651894,"twenty":-5.93877,"median":-2.665519,"eighty":-0.874932,"marketCap":1496873250},{"date":"2025-12-24","current":-5.398557,"twenty":-5.936744,"median":-2.679629,"eighty":-0.878314,"marketCap":1742543287},{"date":"2026-01-02","current":-5.342132,"twenty":-5.93091,"median":-2.713393,"eighty":-0.879024,"marketCap":1731116774},{"date":"2026-01-09","current":-4.766078,"twenty":-5.885949,"median":-2.738651,"eighty":-0.879423,"marketCap":1548292560},{"date":"2026-01-16","current":-4.978531,"twenty":-5.819219,"median":-2.765082,"eighty":-0.879529,"marketCap":1622564897},{"date":"2026-01-23","current":-4.878031,"twenty":-5.803991,"median":-2.784006,"eighty":-0.879587,"marketCap":1588285357},{"date":"2026-01-30","current":-4.681162,"twenty":-5.745279,"median":-2.863181,"eighty":-0.879613,"marketCap":1531152790},{"date":"2026-02-06","current":-4.617051,"twenty":-5.717934,"median":-2.968411,"eighty":-0.881855,"marketCap":1514013020},{"date":"2026-02-13","current":-4.504066,"twenty":-5.69926,"median":-3.043338,"eighty":-0.884318,"marketCap":1485446736},{"date":"2026-02-20","current":-4.579955,"twenty":-5.677229,"median":-3.125093,"eighty":-0.885389,"marketCap":1508299763},{"date":"2026-02-27","current":-3.963988,"twenty":-5.577917,"median":-3.204815,"eighty":-0.887935,"marketCap":1319762293},{"date":"2026-03-06","current":-4.1519,"twenty":-5.469414,"median":-3.251491,"eighty":-0.88893,"marketCap":1371181603},{"date":"2026-03-13","current":-5.217742,"twenty":-5.459149,"median":-3.275714,"eighty":-0.890696,"marketCap":1731116774},{"date":"2026-03-17","current":-5.845785,"twenty":-5.465819,"median":-3.276878,"eighty":-0.891635,"marketCap":1936794014}],"updateTime":1773820712428},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02511\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1152794578","title":"HighTide Therapeutics-B (2511) Schedules 27 March 2026 Board Meeting to Approve FY 2025 Audited Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1152794578","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152794578?lang=en_us&edition=fundamental","pubTime":"2026-03-13 18:04","pubTimestamp":1773396254,"startTime":"0","endTime":"0","summary":"HighTide Therapeutics, Inc. (HIGHTIDE-B, 2511) has announced that its board of directors will convene on Friday, 27 March 2026. The primary agenda is to review and approve the audited consolidated...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02511"],"gpt_icon":0},{"id":"2618932124","title":"HighTide Therapeutics Gets China Acceptance for Type 2 Diabetes Mellitus Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2618932124","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618932124?lang=en_us&edition=fundamental","pubTime":"2026-03-10 19:28","pubTimestamp":1773142132,"startTime":"0","endTime":"0","summary":"HighTide Therapeutics (HKG:2511) received acceptance for its new drug application for HTD1801 from China's National Medical Products Administration, according to a Tuesday Hong Kong bourse filing.The acceptance is for the drug as treatment for type 2 diabetes mellitus.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02511","BK4539","BK1161","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2618093978","title":"BRIEF-HighTide Therapeutics Says NMPA China Accepts New Drug Application For HTD1801","url":"https://stock-news.laohu8.com/highlight/detail?id=2618093978","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618093978?lang=en_us&edition=fundamental","pubTime":"2026-03-10 18:28","pubTimestamp":1773138538,"startTime":"0","endTime":"0","summary":"BRIEF-HighTide Therapeutics Says NMPA China Accepts New Drug Application For HTD1801March 10 (Reuters) - HighTide Therapeutics Inc 2511.HK:ACCEPTANCE OF NEW DRUG APPLICATION FOR HTD1801 BY CHINA'S NMPAFurther company coverage: 2511.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nFWN3ZY074:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02511","BK1161"],"gpt_icon":0},{"id":"1116616793","title":"HighTide-B (02511.HK) Secures NMPA Acceptance of First NDA for HTD1801 in Type 2 Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=1116616793","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116616793?lang=en_us&edition=fundamental","pubTime":"2026-03-10 18:02","pubTimestamp":1773136964,"startTime":"0","endTime":"0","summary":"HighTide Therapeutics, Inc. (HighTide-B, 02511.HK) announced that China’s National Medical Products Administration has formally accepted the company’s New Drug Application for HTD1801, targeting the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02511"],"gpt_icon":0},{"id":"1181902635","title":"HIGHTIDE-B Receives NMPA Acceptance for New Drug Application of HTD1801","url":"https://stock-news.laohu8.com/highlight/detail?id=1181902635","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181902635?lang=en_us&edition=fundamental","pubTime":"2026-03-10 17:28","pubTimestamp":1773134896,"startTime":"0","endTime":"0","summary":"HIGHTIDE-B (02511) announced that China's National Medical Products Administration (NMPA) has accepted the New Drug Application (NDA) for HTD1801 for the treatment of Type 2 Diabetes (T2DM). This...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2618765933","title":"China NMPA accepts HighTide Therapeutics’ HTD1801 NDA for type 2 diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2618765933","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618765933?lang=en_us&edition=fundamental","pubTime":"2026-03-10 17:21","pubTimestamp":1773134516,"startTime":"0","endTime":"0","summary":"HighTide Therapeutics said China’s National Medical Products Administration accepted its new drug application for HTD1801 to treat type 2 diabetes. The company said HTD1801 completed three Phase III trials in type 2 diabetes that met their primary endpoints.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hightide Therapeutics Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 10, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nNDLdrYvh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2618933754","title":"HighTide Therapeutics Inc - Acceptance of New Drug Application for Htd1801 by China's Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2618933754","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618933754?lang=en_us&edition=fundamental","pubTime":"2026-03-10 17:21","pubTimestamp":1773134503,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nFWN3ZY074:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02511","BK1161"],"gpt_icon":0},{"id":"1125516713","title":"HighTide Therapeutics (02511) Announces February 2026 Monthly Return with No Changes in Share Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=1125516713","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125516713?lang=en_us&edition=fundamental","pubTime":"2026-03-02 18:22","pubTimestamp":1772446935,"startTime":"0","endTime":"0","summary":"HighTide Therapeutics, Inc. (02511) presented its monthly return for the period ended 28 February 2026. According to the announcement, the authorized share capital remains at 1,000,000,000 ordinary...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02511"],"gpt_icon":0},{"id":"1176040859","title":"HIGHTIDE-B Completes Phase IIb Trial of HTD1801 for Metabolic Dysfunction-Associated Steatohepatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=1176040859","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176040859?lang=en_us&edition=fundamental","pubTime":"2026-02-05 17:09","pubTimestamp":1770282582,"startTime":"0","endTime":"0","summary":"HIGHTIDE-B (02511) has announced the completion of a global multicenter Phase IIb clinical study of HTD1801 in patients with metabolic dysfunction-associated steatohepatitis (MASH). The CENTRICITY...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02511"],"gpt_icon":0},{"id":"1138862465","title":"HighTide Therapeutics (2511) Completes Phase IIb Trial for HTD1801 in MASH Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1138862465","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138862465?lang=en_us&edition=fundamental","pubTime":"2026-02-05 17:03","pubTimestamp":1770282180,"startTime":"0","endTime":"0","summary":"HighTide Therapeutics, Inc. (Stock Code: 2511) announced the completion of its Phase IIb global multi-regional clinical trial for HTD1801 in patients with metabolic dysfunction-associated...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02511"],"gpt_icon":0},{"id":"2609327844","title":"Hightide Therapeutics Completes Phase IIb Trial of HTD1801 for MASH Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2609327844","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609327844?lang=en_us&edition=fundamental","pubTime":"2026-02-05 16:57","pubTimestamp":1770281859,"startTime":"0","endTime":"0","summary":"HighTide Therapeutics Inc. announced the completion of a Phase IIb clinical study of its investigational drug HTD1801 for the treatment of metabolic dysfunction-associated steatohepatitis . The company reported that while the safety and tolerability of HTD1801 were consistent with previous studies, certain factors such as management of concomitant medications and patient compliance may have impacted the trial results. A post hoc analysis controlling for these confounding factors indicated a trend of therapeutic improvement with HTD1801 compared to placebo. HighTide Therapeutics stated that it will further evaluate its clinical development strategy for the MASH indication based on the overall data and regulatory feedback. The company cautioned that there is no guarantee HTD1801 will ultimately be successfully marketed. The announcement did not specify when or if the detailed study results will be presented.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL7Y2J6k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02511","BK1161"],"gpt_icon":0},{"id":"1105617959","title":"HighTide Therapeutics (02511) Announces January 2026 Monthly Return","url":"https://stock-news.laohu8.com/highlight/detail?id=1105617959","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105617959?lang=en_us&edition=fundamental","pubTime":"2026-02-02 17:06","pubTimestamp":1770023204,"startTime":"0","endTime":"0","summary":"HighTide Therapeutics (02511) has disclosed its Monthly Return for the period ended 31 January 2026, confirming no changes in authorized share capital, which remains 1,000,000,000 ordinary shares at...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02511"],"gpt_icon":0},{"id":"1171669641","title":"HighTide Therapeutics (2511) Announces Appointment of Chief Medical Officer to Advance CKM Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=1171669641","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171669641?lang=en_us&edition=fundamental","pubTime":"2026-02-02 16:50","pubTimestamp":1770022234,"startTime":"0","endTime":"0","summary":"HighTide Therapeutics, Inc. (2511) has appointed Dr. Filip Surmont as Chief Medical Officer to drive the global strategy, clinical development, and medical affairs of its...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02511"],"gpt_icon":0},{"id":"2608652851","title":"HighTide Therapeutics Appoints Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2608652851","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608652851?lang=en_us&edition=fundamental","pubTime":"2026-02-02 16:49","pubTimestamp":1770022192,"startTime":"0","endTime":"0","summary":"HighTide Therapeutics  appointed Filip Surmont as chief medical officer to lead its global medical strategy, clinical development, and medical affairs, according to a Monday Hong Kong bourse filing.Surmont has more than 30 years of healthcare and pharmaceutical experience, including leadership roles at Wyeth, Pfizer, and AstraZeneca, according to the filing.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0058720904.USD","LU0321505439.SGD","LU0225284248.USD","SG9999002232.USD","LU0868494617.USD","LU1066053197.SGD","LU0234572021.USD","IE00BLSP4452.SGD","BK4533","SG9999001176.USD","SG9999011175.SGD","IE00BBT3K403.USD","IE00B19Z3581.USD","BK4550","BK4599","LU1057294990.SGD","BK4592","LU0985481810.HKD","BK4534","SG9999013999.USD","LU1883839398.USD","BK4588","LU1894683264.USD","SG9999002224.SGD","BK4139","LU0225771236.USD","LU0456855351.SGD","SGXZ57979304.SGD","LU0306807586.USD","IE0002270589.USD","BK4585","LU0122379950.USD","BK4581","IE00B19Z3B42.SGD","LENZ","LU1894683348.USD","BK4539","LU0306806265.USD","BK1161","LU0170899867.USD","LU1023059063.AUD","IE00BLSP4239.USD","LU0321505868.SGD","IE000M9KFDE8.USD","SG9999001176.SGD","LU1066051498.USD","BK4568","BK4007","02511"],"gpt_icon":0},{"id":"1111309360","title":"HIGHTIDE-B (02511) Appoints Dr. Filip Surmont as Chief Medical Officer to Strengthen CKM Disease Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=1111309360","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111309360?lang=en_us&edition=fundamental","pubTime":"2026-02-02 16:44","pubTimestamp":1770021859,"startTime":"0","endTime":"0","summary":"HIGHTIDE-B (02511) announced the appointment of Dr. Filip Surmont as Chief Medical Officer. He will assume comprehensive responsibility for the company's medical strategy, clinical development, and...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2608483859","title":"HighTide Therapeutics Appoints Dr. Filip Surmont as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2608483859","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608483859?lang=en_us&edition=fundamental","pubTime":"2026-02-02 16:37","pubTimestamp":1770021453,"startTime":"0","endTime":"0","summary":"HighTide Therapeutics Inc. has appointed Dr. Filip Surmont as Chief Medical Officer. Dr. Surmont will oversee the company's global medical strategy, clinical development, and medical affairs, focusing on advancing HighTide's cardiovascular-kidney-metabolic  syndrome portfolio. The board currently includes Dr. LIU Liping and Ms. YU Meng as executive directors; Dr. ZHU Xun, Mr. MA Lixiong, and Mr. JIANG Feng as non-executive directors; and Mr. TAN Bo, Dr. LI Jin, and Mr. HUNG Tak Wai as independent non-executive directors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hightide Therapeutics Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nNDL1YJLdf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02511"],"gpt_icon":0},{"id":"1113663532","title":"Huatai Securities International Initiates Coverage on HIGHTIDE-B (02511) with \"Buy\" Rating, Sets Target Price at HK$5.78","url":"https://stock-news.laohu8.com/highlight/detail?id=1113663532","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113663532?lang=en_us&edition=fundamental","pubTime":"2025-12-10 17:02","pubTimestamp":1765357337,"startTime":"0","endTime":"0","summary":"Huatai Securities International has released a research report initiating coverage on HIGHTIDE-B (02511), assigning a \"Buy (First-time)\" rating with a six-month target price of HK$5.78. The firm...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02511","161027","BK1161"],"gpt_icon":0},{"id":"1134728285","title":"10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled","url":"https://stock-news.laohu8.com/highlight/detail?id=1134728285","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134728285?lang=en_us&edition=fundamental","pubTime":"2025-12-03 19:38","pubTimestamp":1764761917,"startTime":"0","endTime":"0","summary":"On December 3, 2025, the \"10th Zhitong Capital Market Annual Conference & Listed Companies Awards Ceremony,\" jointly hosted by leading Hong Kong and U.S. stock information platform Zhitong Finance...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1605","03680","IE00BZ08YS42.EUR","BK1171","BK1221","LU0456827905.SGD","LU1224709979.USD","02013","00826","LU0417516571.SGD","00003","01070","01600","BK1618","LNVGY","BK1220","LU2097828805.USD","BK1154","06913","HK0000165453.HKD","IE00BGV7N243.SGD","BK1542","02315","02420","BK1116","IE0009570106.USD","01117","LU0588545904.SGD","LU0165289439.USD","LU2348773727.SGD","BK1148","06996","IE00B0169L03.USD","LU1720050803.USD","02595","03836","00305","SG9999001903.USD","HK0000500386.USD","LU2097828474.EUR","LU0880133367.SGD","BK1175","09877","01651","LU1770034418.SGD","LU0823397285.USD","BK1549","BK1225","LU0054450605.USD","01384","LU0067412154.USD","LU0541502299.USD","BK1095","SGXZ86797644.SGD","06677","LU0502904849.HKD","06100","02145","BK1228","LU0164880469.USD","LU1634259557.SGD","02556","01969","IE00BD6J9T35.USD","02411","BK1615","02096","02506","SG9999000475.SGD","LU0543330566.HKD","06919","01783","LU0314109678.HKD","IE0008369823.USD","BK1552","02197","SG9999001051.SGD","LU0329678337.USD","LU1880383366.USD","LU0819121731.USD","BK1144","02616","BK1197","BK1591","LU2476274308.USD","HK0000306685.HKD","BK1520","00382","LU1008478684.HKD","BK1237","01119","SG9999002828.SGD","LU0370786039.SGD","LU1226288253.USD","LU0456846285.SGD","LU2663582299.SGD","LU0737861772.HKD","LU2488822045.USD","06963","00855","BK1188","LU0823437842.USD","09639","LU0175139822.USD","03145","LU0348827113.USD","IE00B29SXG58.USD","LU1102505762.USD","SG9999001226.SGD","BK1590","LU1242518857.USD","BK1560","LU0469268626.HKD","LU1861219969.SGD","LU0329678170.USD","BK1616","SG9999001093.SGD","00798","SG9999002463.SGD","IE00BYV24P56.USD","LU0588545730.USD","02142","02498","01440","BK1515","LU1794554557.SGD","LU1328615791.USD","02488","LU1497733631.SGD","LU0823038988.USD","00300","02018","BK1131","LU1939255532.USD","02250","LU0463099449.HKD","BK1163","BK1170","02469","02392","02380","LU0823426480.USD","BK1125","LU1282649810.SGD","01520","BK1574","BK1544","LU2543165471.USD","03896","HK0000320264.USD","LU0143863198.USD","LU2399975544.HKD","BK1583","BK1554","LU0831093199.SGD","LU2249611893.SGD","LU0605514214.HKD","SG9999000459.SGD","80992","06060","BK1522","LU1961090484.USD","IE00BGHQDM52.EUR","06086","09990","00861","LU0871576103.HKD","LU2506952253.HKD","BK1158","LU0572939691.SGD","BK1596","06683","BK1128","02511","00512","LU0315179316.USD","03738","BK1219","LU0501845795.SGD","SG9999015945.SGD","LU0289739343.SGD","LU1226287529.USD","01318","LU1951186391.HKD","BK1117","LU0791591158.USD","LU0348805143.USD","06988","09927","03396","LU2506951792.HKD","BK1184","BK1186","LU0594300419.USD","BK1557","IE00B031HY20.USD","LU0865486749.SGD","LU2023250504.SGD","LU0048575426.USD","LU1282649067.USD","IE0032431581.USD","BK1594","BK1100","SG9999015952.SGD","01211","BK1504","LU0823414478.USD","BK1531","02382","06058","00384","LU1226287792.SGD","LU0516423091.SGD","LU0164865239.USD","SG9999011746.SGD","00867","01877","LU0164939612.USD","01952","BK1224","BK1150","01177","02256","09926","09985","LU0211977185.USD","LU2298064838.USD","BK1207","BK1540","06608","00884","LU1023057109.AUD","LU0611395673.USD","LU1251922891.USD","LU1969619763.USD","BK1519","BK1136","SG9999014674.SGD","SGXZ90724238.SGD","BK1597","IE00BPRC5H50.USD","LU1981816686.USD","02158","BK1194","BK1227","BK1212","IE0034224299.USD","LU0384037296.USD","LU1303224171.USD","LU0431992006.USD","BK1124","02400","BK1183","LU2476274720.SGD","LU0620787316.HKD","LU2097828714.EUR","BK1575","IE00B8L5B284.USD","BK1587","01585","IE00BVYPNP33.GBP","LU0261950983.USD","02100","02629","LU2294711713.HKD","81211","BK1604","BK1247","LU1046422090.SGD","BK1528","LU0231483743.USD","BK1229","02509","LU0823426308.USD","BK1126","HK0000252160.HKD","02157","BK1164","HYDD.SI","02268","06613","HK0000320223.HKD","BK1555","LU0264606111.USD","02886","BK1559","01164","BK1595","01405","BK1214","03939","LU0039217434.USD","02889","09923","03681","02167","BK1579","BK1541","BK1571","LU1481107354.HKD","LU1508157978.USD","BK1577","LU1770036033.HKD","LU1868837565.USD","02453","LU0143863784.USD","02171","BK1556","LU0505663152.USD","LU1974910355.USD","LU0540923850.HKD","02105","BK1606","LU1675838814.USD","LU0326950275.SGD","LU0791590937.USD","BK1502","SG9999003461.SGD","IE00BQXX3D17.EUR","BK1539","02587","LU0856984785.SGD","BK1613","HK0000306701.USD","LU2039709279.SGD","BK1239","01458","LU0345776255.USD","LU1497734951.SGD","06160","LU0320764599.SGD","03998","09959","BK1564","02627","LU1956131251.USD","03658","06069","LU0561508036.HKD","LU1152091754.HKD","LU0823414551.USD","LU1808992512.USD","00363","BK1169","BK1139","LU0128525689.USD","LU1366334651.USD","LU1807302812.USD","BK1127","01907","LU1993786604.SGD","BK1110","LU2153592121.USD","00460","SG9999015978.USD","LU0868486357.SGD","LU2045819591.USD","03677","LU0082770016.USD","LU0310800965.SGD","LU0531971595.HKD","01773","LNNGY","LU0594300179.USD","LU2242644610.SGD","LU0708995583.HKD","LU0307460666.USD","BK1167","80020","06657","01735","HK0000252152.HKD","BK1235","02273","09956","LU0488056044.USD","IE00B031J352.USD","LU1102505929.USD","09690","LU2177674079.SGD","LU1522347837.USD","BK1578","LU0048580855.USD","002594","86618","00135","BK1257","02451","LU0449509016.USD","00451","LU1039395188.USD","LU0762540952.USD","LU2153591404.USD","IE00BVYPNQ40.USD","02552","LU0819123356.HKD","BK1619","BK1140","LU0251144936.SGD","01378","BK1523","00875","02460","IE00BQXX3F31.USD","LU0214875030.USD","LU3063872942.SGD","BK1096","BK1215","01818","LU0289961442.SGD","BK1147","LU0359202008.SGD","02121","LU0359201612.USD","LU2778985437.USD","LU0499858438.USD","BK1109","ANPDY","LU0289960550.SGD","LU0315178854.USD","BK1209","BK1589","LU0051755006.USD","BK1119","BK1190","LU0417516902.SGD","06633","SG9999004311.SGD","02020","03650","09961","LU2238339852.HKD","LU0737861699.HKD","BK1608","02650","BK1258","BK1598","IE0003851619.USD","06821","02525","LU0572944931.SGD","LU0229945570.USD","LU0048597586.USD","LU2097828631.EUR","BK1233","02431","IE00B543WZ88.USD","LU1813983027.USD","SG9999002562.SGD","IE00BQXX3C00.GBP","02155","SG9999002950.SGD","00017","09911","01276","06609","BK1141","LU0541501648.USD","03800","06186","06855","BK1553","BK1593","LU0261950470.USD","LU0650527681.SGD","82020","01530","00020","09955","LU0052756011.USD","IE00BMCWC346.EUR","LU0588546209.SGD","LU0348735423.USD","BK1191","LU0052750758.USD","IE0031814852.USD","02150","00656","06090","02551","01093","02858","IE0008368742.USD","LU0588545490.SGD","02419","09878","LU0823039010.USD","01519","BK1155","BK1195","LU0049112450.USD","82331","LU1242518931.SGD","BK1548","LU1328277881.USD","BK1193","BK1134","BK1253","LU1152091168.USD","02228","LU0516422440.USD","BK1161","BK1179","LU0228659784.USD","02276","LU1861214812.USD","SG9999001069.SGD","02590","BK1518","00999","SGXZ62798434.SGD","LU1868838027.USD","LU1917777945.USD","LU1634259391.SGD","LU0043850808.USD","02436","01333","LU2106854487.HKD","BK1114","00777","02057","LU1831875114.USD","09992","LU0072913022.USD","BK1585","LU2348774022.SGD","BK1521","LU2357125470.USD","LU2097828557.USD","01681","LU0516422952.EUR","00699","LU0640798160.USD","09678","09660","LU0455707207.USD","LU2125910500.SGD","SG9999015986.USD","02298","LU1226288170.HKD","BK1527","SG9999006597.SGD","06168","BK1509","LU1188198961.HKD","LU1226287875.USD","02670","BK1216","BK1607","IE00B5MMRT66.SGD","BK1189","LU1719994722.HKD","09996","06618","LU0107464264.USD","BK1550","BK1592","LU0269904917.USD","01640","LU0072462343.USD","LU0348766576.USD","BYDDY","LU0084288322.USD","LU0348783233.USD","09890","LU1211504680.USD","BK1609","LU0287142896.SGD","LU0511384066.AUD","00302","LU0149721374.USD","LU0828237510.HKD","BK1222","LU1868837722.USD","LU0823397103.USD","IE0003795394.USD","LU0449515922.USD","LU2424517915.HKD","BK1524","09860","BK1566","06862","LU0140636845.USD","LU0417516738.SGD","LU0634319403.HKD","LU0348767384.USD","LU0259732245.USD","BK1610","09636","BK1516","BK1600","LU0516423174.USD","LU1880383440.USD","01911","LU0173614495.USD","LU0828238088.HKD","LU1115378108.SGD","BK1160","LU0164872284.USD","00992","SG9999004220.SGD","09919","IE00B8HQ1Z84.USD","02177","BK1111","02331","BK1168","BK1530","BK1617","LU1166156734.SGD","BK1104","IE00BZ08YR35.GBP","SG9999000418.SGD","LU1235295612.USD","LU0509642566.USD","IE00BZ08YT58.USD","02190","LU0979878070.USD","BK1588","LU0348825331.USD","LU0011963245.USD","01939","01448","02567","LU0516422366.SGD","LU2008162690.USD","BK1526","00267","LU0345775950.USD","LU2460026573.USD","BK1143","02533","LU0274383008.USD","LU0593848301.USD","LU0254981946.USD","01762","00960","01880","LU0499858602.USD","LU1048588211.SGD","BK1240","02696","BK1500","09880","LU0531970944.HKD","BK1178","LU1960683339.HKD","06138","IE00B0JY6N72.USD","BK1586","LU0082770016.SGD","LU1497733557.USD","LU2328871848.SGD","01739","BK1200","02598","LU2449936058.SGD","00666","LU0359201885.HKD","03709","LU0244354667.USD","BK1132","LU0702159699.USD","BK1142","01471","BK1230","01809","SG9999006514.SGD","LU1366334578.USD","LU0261947096.USD","LU1267930227.SGD","09699","02279","LU0054237671.USD","LU0348784397.USD","LU0572940350.SGD","BK1151","BK1512","LU2360107325.USD","01833","02565","00136","BK1137","BK1198","LU0251143458.SGD","LU0327786744.USD","BK1582"],"gpt_icon":1},{"id":"1124992441","title":"HighTide Therapeutics (02511) Releases Monthly Return for November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1124992441","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124992441?lang=en_us&edition=fundamental","pubTime":"2025-12-02 16:51","pubTimestamp":1764665510,"startTime":"0","endTime":"0","summary":"HighTide Therapeutics, Inc. (Stock Code: 02511) published its Monthly Return for Equity Issuer on 2 December 2025, reporting no movements in its authorised or issued share capital for November 2025....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02511"],"gpt_icon":0},{"id":"1189634843","title":"HighTide Therapeutics (2511.HK) Reports Positive Phase III HARMONY Trial Results for HTD1801 in T2DM","url":"https://stock-news.laohu8.com/highlight/detail?id=1189634843","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189634843?lang=en_us&edition=fundamental","pubTime":"2025-12-02 08:43","pubTimestamp":1764636186,"startTime":"0","endTime":"0","summary":"HighTide Therapeutics, Inc. (2511.HK) announced that HTD1801 met the primary endpoint in its Phase III HARMONY trial, a head-to-head study against dapagliflozin in patients with type 2 diabetes...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02511"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":30,"code":"91000000","status":"200"}]}}